company background image
BP8 logo

BPH Global ASX:BP8 Stock Report

Last Price

AU$0.0035

Market Cap

AU$1.4m

7D

-12.5%

1Y

-76.7%

Updated

23 Jun, 2024

Data

Company Financials

BP8 Stock Overview

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia.

BP8 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

BPH Global Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BPH Global
Historical stock prices
Current Share PriceAU$0.0035
52 Week HighAU$0.015
52 Week LowAU$0.003
Beta0.89
11 Month Change-30.00%
3 Month Change-30.00%
1 Year Change-76.67%
33 Year Change-95.63%
5 Year Change-95.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

BP8AU BiotechsAU Market
7D-12.5%1.7%0.8%
1Y-76.7%5.3%10.3%

Return vs Industry: BP8 underperformed the Australian Biotechs industry which returned 5.3% over the past year.

Return vs Market: BP8 underperformed the Australian Market which returned 10.3% over the past year.

Price Volatility

Is BP8's price volatile compared to industry and market?
BP8 volatility
BP8 Average Weekly Movement25.3%
Biotechs Industry Average Movement10.8%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: BP8's share price has been volatile over the past 3 months.

Volatility Over Time: BP8's weekly volatility has decreased from 54% to 25% over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1984n/aMatthew Leonardwww.scu.com.sg

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023.

BPH Global Ltd Fundamentals Summary

How do BPH Global's earnings and revenue compare to its market cap?
BP8 fundamental statistics
Market capAU$1.37m
Earnings (TTM)-AU$2.56m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BP8 income statement (TTM)
RevenueAU$0
Cost of RevenueAU$23.94k
Gross Profit-AU$23.94k
Other ExpensesAU$2.54m
Earnings-AU$2.56m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0066
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-70.9%

How did BP8 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.